Literature DB >> 21784752

Both self-report and interview-based measures of psychopathy predict attention abnormalities in criminal offenders.

Joshua D Zeier1, Joseph P Newman.   

Abstract

Historically, psychopathy has been viewed as a clinical syndrome with a unitary etiology, assessed via clinical interview. However, factor analytic studies suggest that psychopathy may also be understood as a combination of two subfactors consisting of (a) interpersonal-affective and (b) lifestyle-antisocial traits. Furthermore, evidence supports the use of self-report measures to assess psychopathy and these subfactors. This investigation employed a Stroop-like task to determine the relationship of the two psychopathy factors, as assessed by both interview-based and self-report measures, to attention-related abnormalities in psychopathy. For both instruments, the factors interacted to predict performance (i.e., interference), though the unique main effects were nonsignificant. The results suggest that the anomalous selective attention of psychopathic offenders is specific to individuals with high scores on both factors. Moreover, these results have important implications for the two-factor model of psychopathy and provide preliminary support for the functional similarity of self-report and interview-based measures of psychopathy.

Entities:  

Keywords:  attention; psychopathic personality inventory; psychopathy; response modulation; two-factor model

Mesh:

Year:  2011        PMID: 21784752      PMCID: PMC3204337          DOI: 10.1177/1073191111415364

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  37 in total

1.  Working memory and stroop interference: an individual differences investigation.

Authors:  Debra L Long; Chantel S Prat
Journal:  Mem Cognit       Date:  2002-03

2.  Stroop tasks reveal abnormal selective attention among psychopathic offenders.

Authors:  Kristina D Hiatt; William A Schmitt; Joseph P Newman
Journal:  Neuropsychology       Date:  2004-01       Impact factor: 3.295

3.  Factor structure of the psychopathic personality inventory: validity and implications for clinical assessment.

Authors:  Stephen D Benning; Christopher J Patrick; Brian M Hicks; Daniel M Blonigen; Robert F Krueger
Journal:  Psychol Assess       Date:  2003-09

4.  Functional differences among those high and low on a trait measure of psychopathy.

Authors:  Heather L Gordon; Abigail A Baird; Alison End
Journal:  Biol Psychiatry       Date:  2004-10-01       Impact factor: 13.382

5.  Alcohol and drug abuse-dependence disorders in psychopathic and nonpsychopathic criminal offenders.

Authors:  S S Smith; J P Newman
Journal:  J Abnorm Psychol       Date:  1990-11

6.  The mechanism of suppression: a component of general comprehension skill.

Authors:  M A Gernsbacher; M E Faust
Journal:  J Exp Psychol Learn Mem Cogn       Date:  1991-03       Impact factor: 3.051

7.  Factor structure of the Psychopathy Checklist.

Authors:  T J Harpur; A R Hakstian; R D Hare
Journal:  J Consult Clin Psychol       Date:  1988-10

8.  Further validation of the psychopathic personality inventory among offenders: personality and behavioral correlates.

Authors:  J F Edens; N G Poythress; M M Watkins
Journal:  J Pers Disord       Date:  2001-10

9.  Statistical difficulties of detecting interactions and moderator effects.

Authors:  G H McClelland; C M Judd
Journal:  Psychol Bull       Date:  1993-09       Impact factor: 17.737

10.  Confirmatory factor analysis of the psychopathy checklist: screening version in offenders with axis I disorders.

Authors:  Christie D Hill; Craig S Neumann; Richard Rogers
Journal:  Psychol Assess       Date:  2004-03
View more
  2 in total

1.  Feature-based attention and conflict monitoring in criminal offenders: interactive relations of psychopathy with anxiety and externalizing.

Authors:  Joshua D Zeier; Joseph P Newman
Journal:  J Abnorm Psychol       Date:  2013-08

2.  Impact of Psychopathy on Moral Judgments about Causing Fear and Physical Harm.

Authors:  Elise M Cardinale; Abigail A Marsh
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.